October 08, 2026 — RNews

#hereditary — Thursday, October 08, 2026 (1 items)

hot top new

← prev day next day →

1

Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial. (linkinghub.elsevier.com)

Riedl MA … Cohn DM The Lancet 2026-10-08

#angioedema #clinical trial #hereditary #pharmacotherapy #bradykinin